ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 131 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $531,000 | -55.9% | 16,080 | -39.9% | 0.04% | -46.3% |
| Q2 2015 | $1,204,000 | +146.7% | 26,755 | +67.7% | 0.07% | +123.3% |
| Q1 2015 | $488,000 | -85.3% | 15,951 | -75.5% | 0.03% | -84.5% |
| Q4 2014 | $3,315,000 | +14.2% | 65,191 | -11.1% | 0.19% | +26.1% |
| Q3 2014 | $2,903,000 | -49.3% | 73,353 | -44.8% | 0.15% | -44.4% |
| Q2 2014 | $5,727,000 | -11.6% | 132,973 | -18.0% | 0.28% | +0.7% |
| Q1 2014 | $6,482,000 | – | 162,100 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |